Literature DB >> 12220224

Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.

Noam Zelcer1, Tohru Saeki, Ilse Bot, Annemieke Kuil, Piet Borst.   

Abstract

Many of the transporters involved in the transport of bile acids in the enterohepatic circulation have been characterized. The basolateral bile-acid transporter of ileocytes and cholangiocytes remains an exception. It has been suggested that rat multidrug resistance protein 3 (Mrp3) fulfills this function. Here we analyse bile-salt transport by human MRP3. Membrane vesicles from insect ( Spodoptera frugiperda ) cells expressing MRP3 show time-dependent uptake of glycocholate and taurocholate. Furthermore, sulphated bile salts were high-affinity competitive inhibitors of etoposide glucuronide transport by MRP3 (IC50 approximately 10 microM). Taurochenodeoxycholate, taurocholate and glycocholate inhibited transport at higher concentrations (IC50 approximately 100, 250 and 500 microM respectively). We used mouse fibroblast-like cell lines derived from mice with disrupted Mdr1a, Mdr1b and Mrp1 genes to generate transfectants that express the murine apical Na+-dependent bile-salt transporter (Asbt) and MRP3. Uptake of glycocholate by these cells is Na+-dependent, with a K(m) and V(max) of 29+/-7 microM and 660 +/- 63 pmol/min per mg of protein respectively and is inhibited by several organic-aniontransport inhibitors. Expression of MRP3 in these cells limits the accumulation of glycocholate and increases the efflux from cells preloaded with taurocholate or glycocholate. In conclusion, we find that MRP3 transports both taurocholate and glycocholate, albeit with low affinity, in contrast with the high-affinity transport by rat Mrp3. Our results suggest that MRP3 is unlikely to be the principal basolateral bile-acid transporter of ileocytes and cholangiocytes, but that it may have a role in the removal of bile acids from the liver in cholestasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12220224      PMCID: PMC1223054          DOI: 10.1042/BJ20021081

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Carrier-mediated transport of conjugated bile acids across the basolateral membrane of biliary epithelial cells.

Authors:  A Benedetti; A Di Sario; L Marucci; G Svegliati-Baroni; C D Schteingart; H T Ton-Nu; A F Hofmann
Journal:  Am J Physiol       Date:  1997-06

2.  Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.

Authors:  A L Craddock; M W Love; R W Daniel; L C Kirby; H C Walters; M H Wong; P A Dawson
Journal:  Am J Physiol       Date:  1998-01

3.  Expression of the bile salt export pump is maintained after chronic cholestasis in the rat.

Authors:  J M Lee; M Trauner; C J Soroka; B Stieger; P J Meier; J L Boyer
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

Review 4.  Sinusoidal (basolateral) bile salt uptake systems of hepatocytes.

Authors:  B Hagenbuch; P J Meier
Journal:  Semin Liver Dis       Date:  1996-05       Impact factor: 6.115

5.  Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter.

Authors:  K N Lazaridis; L Pham; P Tietz; R A Marinelli; P C deGroen; S Levine; P A Dawson; N F LaRusso
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver.

Authors:  T Gerloff; B Stieger; B Hagenbuch; J Madon; L Landmann; J Roth; A F Hofmann; P J Meier
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

7.  Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats.

Authors:  T Hirohashi; H Suzuki; K Ito; K Ogawa; K Kume; T Shimizu; Y Sugiyama
Journal:  Mol Pharmacol       Date:  1998-06       Impact factor: 4.436

8.  Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter.

Authors:  M H Wong; P Oelkers; A L Craddock; P A Dawson
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

9.  Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene.

Authors:  C C Paulusma; P J Bosma; G J Zaman; C T Bakker; M Otter; G L Scheffer; R J Scheper; P Borst; R P Oude Elferink
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728

10.  Taurocholate transport by rat intestinal basolateral membrane vesicles. Evidence for the presence of an anion exchange transport system.

Authors:  S L Weinberg; G Burckhardt; F A Wilson
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

View more
  25 in total

1.  Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis.

Authors:  Joseph L Dempsey; Dongfang Wang; Gunseli Siginir; Qiang Fei; Daniel Raftery; Haiwei Gu; Julia Yue Cui
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 2.  A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.

Authors:  Brandy Garzel; Lei Zhang; Shiew-Mei Huang; Hongbing Wang
Journal:  Curr Drug Metab       Date:  2019       Impact factor: 3.731

Review 3.  The role of transporters in toxicity and disease.

Authors:  John D Schuetz; Peter W Swaan; Donald J Tweedie
Journal:  Drug Metab Dispos       Date:  2014-04       Impact factor: 3.922

4.  Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.

Authors:  Tracy L Marion; Cassandra H Perry; Robert L St Claire; Kim L R Brouwer
Journal:  Toxicol Appl Pharmacol       Date:  2012-02-11       Impact factor: 4.219

5.  Multidrug Resistance-Associated Protein 3 Plays an Important Role in Protection against Acute Toxicity of Diclofenac.

Authors:  Renato J Scialis; Iván L Csanaky; Michael J Goedken; José E Manautou
Journal:  Drug Metab Dispos       Date:  2015-04-20       Impact factor: 3.922

6.  Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception.

Authors:  Noam Zelcer; Koen van de Wetering; Michel Hillebrand; Elise Sarton; Annemieke Kuil; Peter R Wielinga; Thomas Tephly; Albert Dahan; Jos H Beijnen; Piet Borst
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-10       Impact factor: 11.205

7.  Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.

Authors:  Kathleen Köck; Brian C Ferslew; Ida Netterberg; Kyunghee Yang; Thomas J Urban; Peter W Swaan; Paul W Stewart; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2013-10-23       Impact factor: 3.922

Review 8.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

9.  Influence of seeding density and extracellular matrix on bile Acid transport and mrp4 expression in sandwich-cultured mouse hepatocytes.

Authors:  Brandon Swift; Kim L R Brouwer
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

Review 10.  Intestinal transport and metabolism of bile acids.

Authors:  Paul A Dawson; Saul J Karpen
Journal:  J Lipid Res       Date:  2014-09-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.